Global /Taiwan /Healthcare /Biotechnology /6934
chevron_leftBack
HCmed Innovations Co., Ltd. logo

HCmed Innovations Co., Ltd.

6934
TWSE: 6934 Delayed
83.70TWD -0.6%
2.65 USD
As of 22 June 2026, HCmed Innovations Co., Ltd. has a market cap of $86.36M USD, ranking #26581 globally and #1482 in Taiwan. It ranks #2382 in the Healthcare sector, and #461 in the Biotechnology industry.
Global Rank
26581
Country Rank
1482
Sector Rank
2382
Industry Rank
461
Key Stats
Market Cap
$86.36MUSD
2.74B TWD
Enterprise Value
$81.76MUSD
2.59B TWD
Revenue (TTM)
$3.16MUSD
100.23M TWD
EBITDA (TTM)
-$3.45MUSD
-109.17M TWD
Net Income (TTM)
-$3.98MUSD
-126.11M TWD
EBITDA Margin
-109%
Profit Margin
-126%
PS Ratio
27.3
PB Ratio
9.5
Company Profile
Country (HQ)
Sector
Healthcare
Industry
Biotechnology
CEO
Jason Cheng open_in_new
Founded
2014
Website
hcmed-inno.com open_in_new
warningChart data may be delayed
1d 1w 1m 3m 6m 1y
-0.6% -0.9% 15% -46% 27% 34%

News

Loading...

Markets

Exchange Ticker Price
Taiwan Stock Exchange
MIC: XTAI
PRIMARY
6934
心誠鎂行動醫電股份有限公司
ISIN: TW0006934003
Shares Out.:
35.973M1
TV:
SA:
YF:
GF:
BA:
MS:
83.70 TWD
1Market cap is calculated using shares outstanding.
2Float shares are publicly tradable shares, excluding insider-held stock.

About HCmed Innovations Co., Ltd.

HCmed Innovations Co., Ltd. designs, develops, manufactures, and sells respiratory drug delivery systems in the United States, Europe, Africa, and Asia. The company’s products include Pulmogine, a vibrating mesh nebulizer to nebulize a range of liquid medications to treat respiratory diseases and their symptoms in children and adults; and AdheResp, a breath-actuated mesh nebulizer for consumers and healthcare professionals. It also provides intellectual property, advanced technology, customization platforms, manufacturing and commercialization, and APSD analytical services. The company was founded in 2014 and is headquartered in Taipei, Taiwan.

Similar Companies

Industry: Biotechnology (Taiwan)
Name
Market Cap diff.
PE
$5.45B
172.76B TWD
6K%
-
$1.61B
50.93B TWD
2K%
-
$1.07B
34.04B TWD
1K%
-
7827
$724.27M
22.97B TWD
739%
-
7827
$598.62M
18.98B TWD
593%
-
06891
$569.71M
18.06B TWD
560%
-
Industry: Biotechnology (Global)
Name
Market Cap diff.
PE
AMGN
$182.42B
211K%
23.9
GILD
$159.92B
185K%
19.0
ARGX
$47.43B
41.39B EUR
55K%
39.9
$44.62B
68.19T KRW
52K%
35.5
CSL
$42.24B
60.27B AUD
49K%
29.3
LONN
$41.88B
33.71B CHF
48K%
37.2
chevron_leftBack